ubt251
Peptideexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Mar 10, 2025 (NCT07177469)
Timeline
2020s
- Jan 1, 2025
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
GIPR agonist
- Glucagon receptorAGONIST
GCGR agonist
GLP1R agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07145151 | Phase 2 | Sep 30, 2025 | Government of China |
| NCT07134335 | Phase 2 | Sep 1, 2025 | Government of China |
| NCT07163624 | Phase 2 | Mar 22, 2025 | Government of China |
| NCT07177469 | Phase 2 | Mar 10, 2025 | Government of China |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of China | Government | 4 | 4 | 1 | 2025 |
1 organizations
Page 1 / 1